CCR6/CCL20 Chemokine Expression Profile in Distinct Colorectal Malignancies

Scandinavian Journal of Immunology

Volumn 78, Issue 3, 2013, Pages 298-305

  Frick, V O ^a   Rubie, C ^a   Kolsch K ^a   Wagner, M ^a   Ghadjar, P ^b   Graeber, S ^a   Glanemann, M ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR6; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MESSENGER RNA;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER SIZE; CANCER SURGERY; COLORECTAL ADENOMA; COLORECTAL CARCINOMA; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; ULCERATIVE COLITIS; UPREGULATION;

ADENOCARCINOMA; ADENOMA; ADULT; AGED; CHEMOKINE CCL20; COLITIS, ULCERATIVE; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; RECEPTORS, CCR6;

EID: 84883026021     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/sji.12087     Document Type: Article

References (38)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin 2007;57:43-66.
2. Booth RA. Minimally invasive biomarkers for detection and staging of colorectal cancer. Cancer Lett 2007;249:87-96.
3. McLeod HL, MyKay JA, Collie-Duguid ES. Therapeutic opportunities from tumour biology in metastatic colon cancer. Eur J Cancer 2000;36:1706-12.
4. Bogenrieder T, Herlyn M. Axis of evil: molecular mechanisms of cancer metastasis. Oncogene 2003;22:6524-36.
5. Zlotnik A, Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity 2000;12:121-7.
6. Muller A, Homey B, Soto H et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 2004;410:50-6.
7. Schrader AJ, Lechner O, Templin M et al. CXCR4/CXCL12 expression and signalling in kidney cancer. Br J Cancer 2002;86:1250-6.
8. Voermans C, Van Heese WP, De Jong I, Gerritsen WR, van Der Schoot CE. Migratory behavior of leukemic cells from acute myeloid leukemia patients. Leukemia 2002;16:650-7.
9. Taichman RS, Cooper C, Keller ET, Pienta KJ, Taichman NS, McCauley LK. Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone. Cancer Res 2002;62:1832-7.
10. Frick VO, Rubie C, Ghadjar P et al. Changes in CXCL12/CXCR4-chemokine expression during onset of colorectal malignancies. Tumor Biol 2011;32:189-96.
11. Kim J, Takeuchi H, Lam ST et al. Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival. J Clin Oncol 2005;23: 2744-53.
12. Mashino K, Sadanaga N, Yamaguchi H et al. Expression of chemokine receptor CCR7 is associated with lymph node metastasis of gastric carcinoma. Cancer Res 2002;62:2937-41.
13. Ding Y, Shimada Y, Maeda M et al. Association of CC chemokine receptor 7 with lymph node metastasis of esophageal squamous cell carcinoma. Clin Cancer Res 2003;9:3406-12.
14. Takanami I. Overexpression of CCR7 mRNA in non-small cell lung cancer: correlation with lymph node metastasis. Int J Cancer 2003;105:186-9.
15. Cabioglu N, Yazici MS, Arum B et al. CCR7 and CXCR4 as novel biomarkers predicting axillary lymph node metastasis in T1 breast cancer. Clin Cancer Res 2005;11:5686-93.
16. Rubie C, Frick VO, Wagner M et al. Enhanced expression and clinical significance of CC-Chemokine Mip-3alpha in hepatocellular carcinoma. Scand J Immunol 2006;63:468-77.
17. Rubie C, Frick VO, Wagner M et al. Chemokine expression in hepatocellular carcinoma versus colorectal liver metastases. World J Gastroenterol 2006;12:6627-33.
18. Basile J, Thiers B, Maize J Sr, Lathers DM. Chemokine receptor expression in non-melanoma skin cancer. J Cutan Pathol 2008;35:623-9.
19. Rubie C, Frick VO, Ghadjar P et al. CCL20/CCR6 expression profile in pancreatic cancer. J Trans Med 2010;8:45-52.
20. Kleeff J, Kusama T, Rossi DL et al. Detection and localization of MIP3alpha/LARC/Exodus, a macrophage proinflammatory chemokine and its CCR6 receptor in human pancreatic cancer. Int J Cancer 1999;81:650-7.
21. Campell AS, Albo D, Kimsey TF, White SL, Wang TN. CCL20 promotes pancreatic cancer cell invasion by the up-regulation of MMP-9. J Surg Res 2005;123:96-101.
22. Marsigliante S, Vetrugno C, Muscella A. CCL20 induces migration and proliferation on breast epithelial cells. J Cell Physiol 2013;228:1873-83.
23. Rubie C, Oliveira V, Kempf K et al. Involvement of chemokine receptor CCR6 in colorectal cancer metastasis. Tumor Biol 2006;27:166-74.
24. Ghadjar P, Coupland SE, Na IK et al. Chemokine receptor CCR6 expression level and liver metastases in colorectal cancer. J Clin Oncol 2006;24:1910-16.
25. Sobin LH. TNM, sixth edition (2003). New developments in general concepts and rules. Semin Surg Oncol 2003;21:19-22.
26. Bustin SA. Absolute quantification of mRNA using real time reverse transcription polymerase chain reaction assays. J Mol Endocrinol 2000;25:169-93.
27. Rubie C, Kempf K, Hans J et al. Housekeeping gene variability in normal and cancerous colorectal, pancreatic, esophageal, gastric and hepatic tissues. Mol Cell Probes 2005;19:101-9.
28. Schoonjans F, Zalata A, Depuydt CE, Comhaire FH. MedCalc: a new computer program for medical statistics. Comput Methods Programs Biomed 1995;48:257-62.
29. McLean MH, Murray GI, Stewart KN et al. The inflammatory microenvironment in colorectal neoplasia. PLoS ONE 2011;6:e15366.
30. Brand S, Olszak T, Beigel F et al. Cell differentiation dependent expressed CCR6 mediates ERK-1/2, SAPK/JNK, and Akt signaling resulting in proliferation and migration of colorectal cancer cells. J Cell Biochem 2006;97:709-23.
31. Kwon JH, Keates S, Bassani L, Mayer LF, Keates AC. Colonic epithelial cells are a major site of macrophage inflammatory protein 3alpha (MIP-3alpha) production in normal colon and inflammatory bowel disease. Gut 2002;51:818-26.
32. Hieshima K, Imai T, Opdenakker G. Molecular cloning of a novel human CC chemokine liver and activation regulated chemokine (LARC) expressed in liver. Chemotactic activity for lymphocytes and gene localization on chromosome 2. J Biol Chem 1997;272:5846-53.
33. Zeelenberg IS, Ruuls-Van Stalle L, Roos E. The chemokine receptor CXCR4 is required for outgrowth of colon carcinoma micrometastases. Cancer Res 2003;63:3833-9.
34. Shimizu Y, Murata H, Kashii Y et al. CC-chemokine receptor 6 and its ligand macrophage inflammatory protein 3alpha might be involved in the amplification of local necroinflammatory response in the liver. Hepatology 2001;34:311-19.
35. Liu J, Zhang N, Li Q et al. Tumor-associated macrophages recruit CCR6+ regulatory T cells and promote the development of colorectal cancer via enhancing CCL20 production in mice. PLoS ONE 2011;6:e19495.
36. Iwata T, Tanaka K, Inoue Y et al. Macrophage inflammatory protein-3 alpha (MIP-3a) is a novel serum prognostic marker in patients with colorectal cancer. J Surg Oncol 2013;107:160-6.
37. Wang L, Qin H, Li L et al. Overexpression of CCL20 and its receptor CCR6 predicts poor clinical prognosis in human gliomas. Med Oncol 2012;29:3491-7.
38. Johnson Z, Schwarz M, Power CA, Wells TN, Proudfoot AE. Multi-faceted strategies to combat disease by interference with the chemokine system. Trends Immunol 2005;26:268-74.